Thursday, 25 April 2013

Lithuania Pharmaceuticals and Healthcare Report Q2 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Lithuania Pharmaceuticals and Healthcare Report Q2 2013
Apr 24th 2013, 00:00

BMI View: We expect the Lithuanian pharmaceutical market to continue to develop steadily over thecoming years, on account of demographic and epidemiological factors. However, its small populationand downward pressures on prices will continue to hamper the overall potential earnings in the countryfor pharmaceutical companies. Nevertheless, niche areas, such as biopharmaceuticals, will remain ofinterest to foreign majors, also from the point of view of exports.Headline Expenditure Projections?? Pharmaceuticals: LTL1.74bn (US$647mn) in 2012 to LTL1.85bn (US$720mn) in 2013; +6.7%in local currency terms and +11.3% in US dollar terms. Local currency forecast slightly u...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment